rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-1-12
|
pubmed:abstractText |
The results of attempts to identify histopathologic parameters that contribute to the clinical outcome of patients with ependymomas have been controversial. This may be due to the relative rareness of ependymomas. Furthermore, in many investigations, myxopapillary ependymomas and subependymomas were included and may have confounded results, because those tumors should be considered clinicopathologic entities distinct from the other ependymomas.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
388-95
|
pubmed:meshHeading |
pubmed-meshheading:16342252-Adolescent,
pubmed-meshheading:16342252-Adult,
pubmed-meshheading:16342252-Aged,
pubmed-meshheading:16342252-Antibodies, Antinuclear,
pubmed-meshheading:16342252-Antibodies, Monoclonal,
pubmed-meshheading:16342252-Antigens, CD30,
pubmed-meshheading:16342252-Brain Neoplasms,
pubmed-meshheading:16342252-Child,
pubmed-meshheading:16342252-Child, Preschool,
pubmed-meshheading:16342252-Ependymoma,
pubmed-meshheading:16342252-Female,
pubmed-meshheading:16342252-Glioma, Subependymal,
pubmed-meshheading:16342252-Humans,
pubmed-meshheading:16342252-Infant,
pubmed-meshheading:16342252-Infant, Newborn,
pubmed-meshheading:16342252-Male,
pubmed-meshheading:16342252-Middle Aged,
pubmed-meshheading:16342252-Prognosis
|
pubmed:year |
2006
|
pubmed:articleTitle |
Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
|
pubmed:affiliation |
Department of Neurosurgery, Erasmus Medical Center, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article
|